Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

CYDY has ALWAYS BEEN UNBLINDED on CD12?!?!?!? T

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154897
(Total Views: 722)
Posted On: 01/10/2021 8:54:52 PM
Posted By: havasu78
Re: Enjay #72086
CYDY has ALWAYS BEEN UNBLINDED on CD12?!?!?!?

That post is way beyond an "interesting read".

That post is an unequivocal claim that CYDY has always known the results of the CD12 trial in real time as they have developed.

If true, every comment and action by Pourhassan must be re-examined in light of the possiblity that Pourhassan and possibly every other CYDY employee knows the CD12 primary endpoint progress and has known this progress from the first day the first CD12 patient was dosed.

"Knowing the results" is not quite the same thing as "unblinded", but as a practical matter there absolutely is no difference if I am a CYDY employee who wants to know how CD12 is progressing.

There are only three predicates, the first two claimed by Science+Compliance as facts, upon which the claim that CYDY has always known real-time CD12 results:

1) A file named eTMF exists and that file includes the medical records of CD12 patients.

2) Someone at CYDY can open that file and review the medical records.

3) Pourhassan elected to review the eTMF file and the CD12 results it provides.

Can anyone comment on whether these predicates are possible? Is there really such thing as an eTMF file? Does it include all of the CD12 patient medical records, including blood test results?

Finally, and most importantly, who at CYDY is allowed to access the eTMF and are they allowed to publicly reveal what they learned from the eTMF?

A serious deficit in Science+Compliance's analysis is that he does not understand leronlimab and CCR5.

CCR5 receptor occupancy, which is performed on all CD12 patients, distinguishes between leronlimab and placebo arms with 100% accuracy. Science+Compliance discusses RANTES, bilirubin and others in the context of whether or not the medical records can indicate LL or placebo, but none of those are relevant. CCR5 receptor occupancy is 100% dispositiv of who got LL and who is on placebo.

So if there exists an electronic file that contains medical records for all CD12 patients, and if that file is accessible to CYDY employees, then anyone at CYDY interested to look can see the CD12 progress in real time.


(2)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us